Linezolid Pharmacokinetics and Pharmacodynamics in the Treatment of Multi-Drug Resistant and Extensively-Drug Resistant Tuberculosis.

Trial Profile

Linezolid Pharmacokinetics and Pharmacodynamics in the Treatment of Multi-Drug Resistant and Extensively-Drug Resistant Tuberculosis.

Completed
Phase of Trial: Phase I/II

Latest Information Update: 18 Jun 2014

At a glance

  • Drugs Linezolid (Primary)
  • Indications Tuberculosis
  • Focus Pharmacokinetics
  • Most Recent Events

    • 11 Oct 2011 Actual initiation date changed from Dec 2009 to Apr 2009 as reported by ClinicalTrials.gov.
    • 16 Jul 2010 Actual end date (May 2010) added as reported by ClinicalTrials.gov.
    • 16 Jul 2010 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top